154 related articles for article (PubMed ID: 32237256)
1. Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
St Germain D; Denicoff A; Torres A; Kelaghan J; McCaskill-Stevens W; Mishkin G; O'Mara A; Minasian LM
Cancer; 2020 Jun; 126(11):2687-2693. PubMed ID: 32237256
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Di Costanzo F; Napolitano F; Salomone F; Amato AR; Alberico G; Migliaccio F; Pecoraro G; Marra A; Crocetto F; Ruffo A; Scagliarini S; Rossetti S; Puglia L; Di Napoli M; Bianco R; Servetto A; Formisano L
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067406
[TBL] [Abstract][Full Text] [Related]
4. Health related quality of life in NCI-sponsored cancer treatment trials.
O'Mara AM; Denicoff AM
Semin Oncol Nurs; 2010 Feb; 26(1):68-78. PubMed ID: 20152580
[TBL] [Abstract][Full Text] [Related]
5. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
[TBL] [Abstract][Full Text] [Related]
6. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.
Fiteni F; Ray IL; Ousmen A; Isambert N; Anota A; Bonnetain F
BMC Cancer; 2019 Apr; 19(1):361. PubMed ID: 30991990
[TBL] [Abstract][Full Text] [Related]
8. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
Efficace F; Osoba D; Gotay C; Sprangers M; Coens C; Bottomley A
Ann Oncol; 2007 Apr; 18(4):775-81. PubMed ID: 17259641
[TBL] [Abstract][Full Text] [Related]
9. The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review.
Gaertner J; Weingärtner V; Lange S; Hausner E; Gerhardus A; Simon ST; Voltz R; Becker G; Schmacke N
PLoS One; 2015; 10(9):e0136640. PubMed ID: 26327232
[TBL] [Abstract][Full Text] [Related]
10. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
[TBL] [Abstract][Full Text] [Related]
11. Symptom science research conducted in community programs funded by the US National Cancer Institute: a 12-year review, 2008 to 2019.
Germain DS; Stevens WM; O'Mara A
Support Care Cancer; 2022 Jun; 30(6):4739-4746. PubMed ID: 35122531
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life.
Winters ZE; Benson JR; Pusic AL
Ann Surg; 2010 Dec; 252(6):929-42. PubMed ID: 20729711
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.
Kovic B; Jin X; Kennedy SA; Hylands M; Pedziwiatr M; Kuriyama A; Gomaa H; Lee Y; Katsura M; Tada M; Hong BY; Cho SM; Hong PJ; Yu AM; Sivji Y; Toma A; Xie L; Tsoi L; Waligora M; Prasad M; Bhatnagar N; Thabane L; Brundage M; Guyatt G; Xie F
JAMA Intern Med; 2018 Dec; 178(12):1586-1596. PubMed ID: 30285081
[TBL] [Abstract][Full Text] [Related]
14. Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis.
Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT
Lancet Oncol; 2011 Dec; 12(13):1240-8. PubMed ID: 21996168
[TBL] [Abstract][Full Text] [Related]
15. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute.
Gordon D; Cooper-Arnold K; Lauer M
J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845
[TBL] [Abstract][Full Text] [Related]
16. Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance.
Trask PC; Hsu MA; McQuellon R
Cancer J; 2009; 15(5):435-40. PubMed ID: 19826365
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer.
Adamowicz K; Saad ED; Jassem J
Cancer Treat Rev; 2016 Nov; 50():194-199. PubMed ID: 27718458
[TBL] [Abstract][Full Text] [Related]
18. Health related quality of life outcomes in cancer clinical trials.
Bottomley A; Flechtner H; Efficace F; Vanvoorden V; Coens C; Therasse P; Velikova G; Blazeby J; Greimel E;
Eur J Cancer; 2005 Aug; 41(12):1697-709. PubMed ID: 16043345
[TBL] [Abstract][Full Text] [Related]
19. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.
Osoba D; Bezjak A; Brundage M; Zee B; Tu D; Pater J;
Eur J Cancer; 2005 Jan; 41(2):280-7. PubMed ID: 15661554
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.
Prindiville SA; Sarosy GA; Loose D; Ciolino H; Doroshow JH
Cancer J; 2022 Mar-Apr 01; 28(2):111-117. PubMed ID: 35333495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
